Vor Biopharma Inc. Payments to Acquire Investments
Vor Biopharma Inc. (VOR) reported Payments to Acquire Investments of $87.76 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-14.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquireInvestments · last filed 2022-03-14
- Vor Biopharma Inc. payments to acquire investments for the quarter ending 2021-12-31 was $4.79M.
- Vor Biopharma Inc. payments to acquire investments for the quarter ending 2021-09-30 was $7.85M.
- Vor Biopharma Inc. payments to acquire investments for fiscal 2021 was $87.76M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $12.63M derived: sum of 2 quarters · filed 2022-03-14 | $87.76M 10-K · filed 2022-03-14 | |
| 2021-09-30 | $7.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $82.97M 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $75.12M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |